DeepMed Research

Minneapolis Heart Institute Foundation

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1982-01-01

Employees: -

Market Cap: -

Website: https://mplsheart.org/

Clinical Trials

The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial

Phase 4

Terminated

Conditions: Saphenous Vein Graft Atherosclerosis

Interventions: Drug: Matching Placebo subcutaneous injection
Drug: Alirocumab 150 MG/ML subcutaneous injection

First Posted Date: 2018-05-31

Last Posted Date: 2021-09-16

Lead Sponsor: Minneapolis Heart Institute Foundation

Target Recruit Count: 46

Registration Number: NCT03542110

Locations: 🇺🇸
San Francisco VA Medical Center, San Francisco, California, United States
🇺🇸
Atlanta VA Medical Center, Atlanta, Georgia, United States
🇺🇸
Minneapolis Heart Institute/ Abbott North Western Hospital-Allina Health, Minneapolis, Minnesota, United States

and more 1 locations

REduction of Contrast Via DyeVert Used in CTO Procedures

Terminated

Conditions: Chronic Total Occlusion of Coronary Artery

Interventions: Device: DyeVert System

First Posted Date: 2017-04-18

Last Posted Date: 2018-05-17

Lead Sponsor: Minneapolis Heart Institute Foundation

Target Recruit Count: 21

Registration Number: NCT03118544

Locations: 🇺🇸
Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
🇺🇸
Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, United States
🇺🇸
Minneapolis Heart Institute, Minneapolis, Minnesota, United States

diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED)

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Behavioral: Coaching

First Posted Date: 2016-12-02

Last Posted Date: 2019-07-29

Lead Sponsor: Minneapolis Heart Institute Foundation

Target Recruit Count: 118

Registration Number: NCT02980978

Endovascular Aneurysm Repair (EVAR) Gate Study

Not Applicable

Completed

Conditions: Abdominal Aortic Aneurysm (AAA)

Interventions: Procedure: Endovascular Aneurysm Repair

First Posted Date: 2016-10-14

Last Posted Date: 2016-10-14

Lead Sponsor: Minneapolis Heart Institute Foundation

Target Recruit Count: 102

Registration Number: NCT02934087

Locations: 🇺🇸
Minneapolis Heart Institute, Minneapolis, Minnesota, United States

The SHINE-CTO Trial

Not Applicable

Withdrawn

Conditions: Percutaneous Transluminal Coronary Angioplasty
Chronic Total Occlusion of Coronary Artery
Coronary Artery Disease

Interventions: Procedure: Chronic Total Occlusion Percutaneous Coronary Intervention
Procedure: Sham Procedure

First Posted Date: 2016-05-27

Last Posted Date: 2021-06-07

Lead Sponsor: Minneapolis Heart Institute Foundation

Registration Number: NCT02784418

Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

Conditions: Coronary Artery Disease

First Posted Date: 2014-02-12

Last Posted Date: 2022-03-10

Lead Sponsor: Minneapolis Heart Institute Foundation

Target Recruit Count: 2000

Registration Number: NCT02061436

Locations: 🇺🇸
Emory University Hospital- Emory Heart and Vascular Center, Atlanta, Georgia, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
University Hospitals (UH) Case Western Reserve University, Cleveland, Ohio, United States

and more 45 locations

Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)

Phase 1

Completed

Conditions: Acute Myocardial Infarction

Interventions: Procedure: Post Conditioning + Primary PCI
Procedure: Standard Primary PCI

First Posted Date: 2011-03-29

Last Posted Date: 2019-06-05

Lead Sponsor: Minneapolis Heart Institute Foundation

Target Recruit Count: 103

Registration Number: NCT01324453

Locations: 🇺🇸
Abbott Northwestern Hospital, Minneapolis, Minnesota, United States

Coronary Artery Disease (CAD) in Women Marathon Runners

Completed

Conditions: Coronary Artery Disease

First Posted Date: 2009-06-11

Last Posted Date: 2010-09-13

Lead Sponsor: Minneapolis Heart Institute Foundation

Target Recruit Count: 50

Registration Number: NCT00918372

Locations: 🇺🇸
Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, Minnesota, United States

Alternative in Beta Blocker Intolerance: The ABBI Trial

Phase 4

Terminated

Conditions: Coronary Artery Disease

Interventions: Drug: Nebivolol

First Posted Date: 2009-05-06

Last Posted Date: 2019-08-06

Lead Sponsor: Minneapolis Heart Institute Foundation

Target Recruit Count: 6

Registration Number: NCT00893984

Locations: 🇺🇸
Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, Minnesota, United States

Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin

Completed

Conditions: Non-STEMI Acute Coronary Syndrome

First Posted Date: 2009-02-12

Last Posted Date: 2013-04-25

Lead Sponsor: Minneapolis Heart Institute Foundation

Target Recruit Count: 32

Registration Number: NCT00842374

Locations: 🇺🇸
Ridgeview Medical Center, Waconia, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy